Most income investors have never considered options-overlay ETFs, yet three funds are quietly delivering double-digit annual distribution rates paid monthly or weekly.

The YieldMax Ultra Option Income Strategy ETF (NYSEARCA: ULTY), NEOS Nasdaq-100 High Income ETF (NASDAQ: QQQI), and NEOS S&P 500 High Income ETF (CBOE: SPYI) each convert equity volatility into cash through distinct structural approaches.

ULTY is currently throwing off roughly 50% annualized through weekly distributions, making it the most aggressive income vehicle of the three by a considerable margin.

QQQI and SPYI take a more measured approach, using tax-aware index call writing to generate monthly payouts well into the double digits while preserving meaningful exposure to their respective underlying indexes.

Persistent equity volatility through 2025 and into 2026 has kept option premiums elevated, continuously refilling the income well these funds rely on to sustain their distributions.

SPYI has grown to $10 billion in assets under management, while ULTY has scaled to approximately $872 million, both figures representing sharp increases from a year ago.

ULTY runs a synthetic covered call strategy across a rotating book of the most volatile, most-traded single stocks in the U.S. market, with current top holdings including Astera Labs, IREN Limited, AMD, Fortinet, Coherent, Palantir, Robinhood, Quanta Services, Analog Devices, Comfort Systems, and the VanEck Gold Miners ETF.

Recent ULTY weekly distributions have clustered around $0.39 to $0.40 per share, with May 2026 paying out roughly $1.59 across four weeks, against a share price near $32 and an expense ratio of 1.30%.

The central tradeoff for ULTY investors is NAV decay, as the fund’s total return over the trailing year was approximately 10% on a price-adjusted basis, meaning nearly all income was offset by limited principal growth.

QQQI holds the Nasdaq-100 basket and overlays a data-driven call-writing program using NDX index options, which qualify for Section 1256 60/40 tax treatment, blending long-term and short-term capital gains rates favorably.

The fund has paid 12 monthly distributions over the past year ranging from roughly $0.53 to $0.66 per share, with the most recent May 2026 payment at $0.6589 against a share price of nearly $58, producing a distribution rate just under 14%.

Notably, QQQI’s share price has appreciated approximately 32% over the trailing year, meaning the income has been genuinely additive rather than simply a return of eroded principal.

The primary limitation for QQQI investors is capped upside, as the short call overlay will cause the fund to lag meaningfully during a sharp Nasdaq rally.

SPYI operates the same NEOS strategy applied to the S&P 500, holding index constituents directly and writing data-driven SPX index calls that also qualify for the 1256 60/40 tax treatment, with an inception date of August 2022.

Monthly distributions for SPYI have been consistent, with a May 2026 payment of $0.5353 per share and a range of $0.46 to $0.56 per share each month since 2024, producing a distribution rate near 11.5% against a share price of $54.

SPYI’s total return over the past year reached 24%, and the fund has compounded to a 73% gain since inception, demonstrating that the call-writing overlay has not materially undermined the underlying return engine.

Both NEOS funds carry an expense ratio of 0.68%, which is competitive for actively managed income strategies of this complexity.

Investors considering all three funds together could structure a reasonable barbell approach, using SPYI and QQQI for index-grade compounding with tax efficiency while allocating a smaller position to ULTY to capture additional cash flow from single-stock volatility.

The core question across all three funds is how much principal stability an investor is willing to trade for yield, a calculation that differs significantly depending on whether the goal is retirement income, cash flow generation, or total return.

For income-focused investors in taxable accounts, the Section 1256 tax treatment embedded in both NEOS funds adds a meaningful structural advantage that pure dividend strategies and most covered call ETFs cannot match.